Business Development Services:
	Identifying and Evaluating Development Opportunities
Partners LLC: Biomedical Consulting

Identification of potential development and/or licensing candidates

Whether a new product candidate originated from your firm’s internal R & D group, a university or an industrial source, you need to successfully determine (1) its commercial and technical potential and (2) its strategic fit for your company’s mission and product profile.

LSP’s principals have more than two decades of experience in evaluating development opportunities and in formulating product development and licensing strategies. Collectively, they have performed well over 100 assessments of development opportunities.  They have taken several opportunities through the path leading to corporate approval for adoption and development. LSP is thus well-qualified to assist you to find products to in-license for development, as well as to identify, assess and qualify corporate partners for out-licensing an in-house product.

Assessment of Development Opportunities

For any development candidate, a systematic evaluation should be performed.  This examination will determine its potential for success; it should also assess whether the candidate is best adopted internally for development and commercialization, licensed as a new product, or licensed out as a revenue source. Components of this assessment that will be performed, as required, are:

• Strategic fit and complementarity to current product line(s)

• Scientific and therapeutic rationale

• Technical merit

• Technical aspects of intellectual property position

• Potential for clinical success

• Likelihood of regulatory approval; identification of regulatory hurdles

• Regulatory requirements for preclinical and clinical development

• Market analyses, including profiles of competing products on the market or in development

• Potential for commercial success

• Identify and develop strategies to deal with reimbursement and third-party payer issues

• Income projections (profit and loss, cash flow), return on investment (ROI), net present value (NPV)

• Technology transfer issues

• Manufacturing and scale-up issues

• Identify therapeutic thought leaders for independent assessment

• Development time line

Establishment of Corporate Consensus for Development Opportunities

• Identify stakeholders for licensing opportunities

• Identify and address internal corporate issues

• Presentations to corporate management